Chlamydia trachomatis intra-bacterial and total plasmid copy number in clinical urogenital samples.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 01 2021
Historique:
received: 09 07 2019
accepted: 22 12 2020
entrez: 9 1 2021
pubmed: 10 1 2021
medline: 17 8 2021
Statut: epublish

Résumé

Chlamydia trachomatis (CT) increases its plasmid numbers when stressed, as occurs in clinical trachoma samples. Most CT tests target the plasmid to increase the test sensitivity, but some only target the chromosome. We investigated clinical urogenital samples for total plasmid copy numbers to assess its diagnostic value and intra-bacterial plasmid copy numbers to assess its natural variation. Both plasmid and chromosome copies were quantified using qPCR, and the plasmid:chromosome ratio (PCr) calculated in two cohorts: (1) 383 urogenital samples for the total PCR (tPCr), and (2) 42 vaginal swabs, with one half treated with propium-monoazide (PMA) to prevent the quantification of extracellular DNA and the other half untreated to allow for both tPCr and intra-bacterial PCr (iPCr) quantification. Mann-Whitney U tests compared PCr between samples, in relation to age and gender. Cohort 1: tPCr varied greatly (1-677, median 16). Median tPCr was significantly higher in urines than vaginal swabs (32 vs. 11, p < 0.001). Cohort 2: iPCr was more stable than tPCr (range 0.1-3 vs. 1-11). To conclude, tPCr in urogenital samples was much more variable than previously described. Transport time and temperature influences DNA degradation, impacting chromosomal DNA more than plasmids and urine more than vaginal samples. Data supports a plasmid target in CT screening assays to increase clinical sensitivity.

Identifiants

pubmed: 33420252
doi: 10.1038/s41598-020-80645-y
pii: 10.1038/s41598-020-80645-y
pmc: PMC7794532
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

259

Références

PLoS One. 2015 Mar 31;10(3):e0121433
pubmed: 25826298
J Infect Dis. 2010 Jun 15;201 Suppl 2:S134-55
pubmed: 20470050
Plasmid. 1990 Mar;23(2):144-8
pubmed: 2362949
Infect Immun. 1998 Dec;66(12):6010-3
pubmed: 9826386
Microbiology (Reading). 2005 Mar;151(Pt 3):893-903
pubmed: 15758234
PLoS One. 2016 Nov 3;11(11):e0165920
pubmed: 27812208
Infect Immun. 2011 Jul;79(7):2502-9
pubmed: 21555398
Euro Surveill. 2006 Nov 09;11(11):E061109.2
pubmed: 17213548
Appl Environ Microbiol. 2006 Mar;72(3):1997-2004
pubmed: 16517648
J Exp Med. 2011 Oct 24;208(11):2159-62
pubmed: 22025500
J Clin Microbiol. 1999 Apr;37(4):976-80
pubmed: 10074512
J Microbiol Methods. 2006 Nov;67(2):310-20
pubmed: 16753236
FEMS Microbiol Rev. 2014 Nov;38(6):1089-90
pubmed: 25382416
Pathog Dis. 2014 Feb;70(1):61-9
pubmed: 24022847
Curr Opin Infect Dis. 2011 Feb;24(1):62-9
pubmed: 21157332
Microbiol Res. 2013 Jul 19;168(6):333-339
pubmed: 23590987
J Gen Microbiol. 1984 Jan;130(1):217-22
pubmed: 6368744
Heliyon. 2017 Jul 26;3(7):e00364
pubmed: 28795162
Biotechniques. 2003 Apr;34(4):804-8, 810, 812-3
pubmed: 12703305
J Clin Microbiol. 1993 Jul;31(7):1753-8
pubmed: 7688753
Microorganisms. 2016 Aug 05;4(3):
pubmed: 27681919
Plasmid. 1986 Jul;16(1):52-62
pubmed: 3016782
J Clin Microbiol. 2014 Jan;52(1):324-7
pubmed: 24197878
MMWR Recomm Rep. 2014 Mar 14;63(RR-02):1-19
pubmed: 24622331
Infect Immun. 2013 Mar;81(3):636-44
pubmed: 23319558
J Clin Microbiol. 2013 Mar;51(3):990-2
pubmed: 23254134

Auteurs

J A M C Dirks (JAMC)

Department of Medical Microbiology, Maastricht University Medical Center, Care and Public Health Research Institute (Caphri), Maastricht, The Netherlands. anne.dirks@mumc.nl.
Department of Sexual Health, Infectious Diseases and Environmental Health, Public Health Service South Limburg, Geleen, The Netherlands. anne.dirks@mumc.nl.

K Janssen (K)

Department of Medical Microbiology, Maastricht University Medical Center, Care and Public Health Research Institute (Caphri), Maastricht, The Netherlands.
Department of Sexual Health, Infectious Diseases and Environmental Health, Public Health Service South Limburg, Geleen, The Netherlands.

C J P A Hoebe (CJPA)

Department of Medical Microbiology, Maastricht University Medical Center, Care and Public Health Research Institute (Caphri), Maastricht, The Netherlands.
Department of Sexual Health, Infectious Diseases and Environmental Health, Public Health Service South Limburg, Geleen, The Netherlands.

T H B Geelen (THB)

Department of Medical Microbiology, Maastricht University Medical Center, Care and Public Health Research Institute (Caphri), Maastricht, The Netherlands.

M Lucchesi (M)

Department of Medical Microbiology, Maastricht University Medical Center, Care and Public Health Research Institute (Caphri), Maastricht, The Netherlands.

N H T M Dukers-Muijrers (NHTM)

Department of Medical Microbiology, Maastricht University Medical Center, Care and Public Health Research Institute (Caphri), Maastricht, The Netherlands.
Department of Sexual Health, Infectious Diseases and Environmental Health, Public Health Service South Limburg, Geleen, The Netherlands.

P F G Wolffs (PFG)

Department of Medical Microbiology, Maastricht University Medical Center, Care and Public Health Research Institute (Caphri), Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH